Manhunt was released in 2003 on the PS2, and it’s still one of the darkest games Rockstar ever put out. It starred a death ...

Some of the best game franchises have come and gone. Here are 10 beloved gaming franchises that quietly died without anyone ...

Chasing a reason for the slight apathy towards a hugely successful generation, we compare Sony's PS5 exclusives to the PS4s - ...

Released in 2001, a year stacked with amazing games, Ico is considered by many to be the best PS2 game. Developed by Sony Computer Entertainment Japan, this game came out of nowhere. It became ...

Is something going on between Kylie Padilla and Jak Roberto? In Nelson Canlas's report on "24 Oras," Tuesday, Gabby Concepcion teased his "My Father's Wife" co-stars about developing feelings while ...

PS2 emulator NetherSX2 has released update 2.1, providing a nice performance boost. The update also fixes regressions and visual bugs introduced in version 2.0. There are two versions with different ...

A meta-analysis showed no significant differences between JAK inhibitor use and TNF antagonist use in terms of the risk for serious infections or malignant neoplasms in patients with immune-mediated ...

Jake brings two decades of experience with him, having covered major industry events, breaking news, one-on-one interviews, and more. When he's not playing World of Warcraft, he's usually on the hunt ...

The resurgence of 3D platformers is still ongoing after Astro Bot’s release. Nintendo is giving us a new 3D Donkey Kong on Switch 2, and classic icons like Croc are getting re-releases. Even if we don ...

The Ratchet and Clank series has always been a hard series to mess up, often giving fans good platforming and great weapon-based combat. You could argue that every game in this franchise is the same, ...

GameSpot may get a commission from retail offers. This week's Triple- Initiative covered a wide range of genres, but for anyone looking for a retro-inspired platformer, then Duskfade was likely the ...

Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical counterpart Opzelura, have been the company’s driving focus for years. Now, with Jakafi approaching a 2028 ...